Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria De Santis

Showing results (221-230 of 278) with videos related to

Pageof 28
Sort By:
RMD Open|March 20, 2019
Overall mortality in combined pulmonary fibrosis and emphysema related to systemic sclerosisAlarico Ariani, Mario Silva, Elena Bravi, et al.
European Urology|March 25, 2017
What Is the Negative Predictive Value of Multiparametric Magnetic Resonance Imaging in Excluding Prostate Cancer at Biopsy? A Systematic Review and Meta-analysis from the European Association of Urology Prostate Cancer Guidelines PanelPaul C Moldovan, Thomas Van den Broeck, Richard Sylvester, et al.
European Urology|May 8, 2021
A Systematic Review of the Impact of Surgeon and Hospital Caseload Volume on Oncological and Nononcological Outcomes After Radical Prostatectomy for Nonmetastatic Prostate CancerThomas Van den Broeck, Daniela Oprea-Lager, Lisa Moris, et al.
Rheumatology (Oxford, England)|September 30, 2024
Long-term retention rate, adverse event temporal patterns and rescue treatment strategies of mycophenolate mofetil in systemic sclerosis: insights from real-lifeEnrico De Lorenzis, Gerlando Natalello, Greta Pellegrino, et al.
European Urology|September 24, 2023
European Association of Nuclear Medicine Focus 5: Consensus on Molecular Imaging and Theranostics in Prostate CancerDaniela-Elena Oprea-Lager, Steven MacLennan, Anders Bjartell, et al.
Clinical Rheumatology|January 29, 2022
Systemic syndromes of rheumatological interest with onset after COVID-19 vaccine administration: a report of 30 casesFrancesco Ursini, Piero Ruscitti, Vincenzo Raimondo, et al.
Cell Reports. Medicine|January 27, 2024
Immunomodulatory effects and improved outcomes with cisplatin- versus carboplatin-based chemotherapy plus atezolizumab in urothelial cancerMatthew D Galsky, Xiangnan Guan, Deepali Rishipathak, et al.
European Urology|November 11, 2020
EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative IntentNicolas Mottet, Roderick C N van den Bergh, Erik Briers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 8, 2023
Pembrolizumab Plus Olaparib for Patients With Previously Treated and Biomarker-Unselected Metastatic Castration-Resistant Prostate Cancer: The Randomized, Open-Label, Phase III KEYLYNK-010 TrialEmmanuel S Antonarakis, Se Hoon Park, Jeffrey C Goh, et al.
European Urology|October 22, 2018
Prognostic Value of Biochemical Recurrence Following Treatment with Curative Intent for Prostate Cancer: A Systematic ReviewThomas Van den Broeck, Roderick C N van den Bergh, Nicolas Arfi, et al.
Pageof 28

Showing results (221-230 of 278) with videos related to

Sort By:
Pageof 28
RMD Open|March 20, 2019
Overall mortality in combined pulmonary fibrosis and emphysema related to systemic sclerosisAlarico Ariani, Mario Silva, Elena Bravi, et al.
European Urology|March 25, 2017
What Is the Negative Predictive Value of Multiparametric Magnetic Resonance Imaging in Excluding Prostate Cancer at Biopsy? A Systematic Review and Meta-analysis from the European Association of Urology Prostate Cancer Guidelines PanelPaul C Moldovan, Thomas Van den Broeck, Richard Sylvester, et al.
European Urology|May 8, 2021
A Systematic Review of the Impact of Surgeon and Hospital Caseload Volume on Oncological and Nononcological Outcomes After Radical Prostatectomy for Nonmetastatic Prostate CancerThomas Van den Broeck, Daniela Oprea-Lager, Lisa Moris, et al.
Rheumatology (Oxford, England)|September 30, 2024
Long-term retention rate, adverse event temporal patterns and rescue treatment strategies of mycophenolate mofetil in systemic sclerosis: insights from real-lifeEnrico De Lorenzis, Gerlando Natalello, Greta Pellegrino, et al.
European Urology|September 24, 2023
European Association of Nuclear Medicine Focus 5: Consensus on Molecular Imaging and Theranostics in Prostate CancerDaniela-Elena Oprea-Lager, Steven MacLennan, Anders Bjartell, et al.
Clinical Rheumatology|January 29, 2022
Systemic syndromes of rheumatological interest with onset after COVID-19 vaccine administration: a report of 30 casesFrancesco Ursini, Piero Ruscitti, Vincenzo Raimondo, et al.
Cell Reports. Medicine|January 27, 2024
Immunomodulatory effects and improved outcomes with cisplatin- versus carboplatin-based chemotherapy plus atezolizumab in urothelial cancerMatthew D Galsky, Xiangnan Guan, Deepali Rishipathak, et al.
European Urology|November 11, 2020
EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative IntentNicolas Mottet, Roderick C N van den Bergh, Erik Briers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 8, 2023
Pembrolizumab Plus Olaparib for Patients With Previously Treated and Biomarker-Unselected Metastatic Castration-Resistant Prostate Cancer: The Randomized, Open-Label, Phase III KEYLYNK-010 TrialEmmanuel S Antonarakis, Se Hoon Park, Jeffrey C Goh, et al.
European Urology|October 22, 2018
Prognostic Value of Biochemical Recurrence Following Treatment with Curative Intent for Prostate Cancer: A Systematic ReviewThomas Van den Broeck, Roderick C N van den Bergh, Nicolas Arfi, et al.
Pageof 28